Development of engineered transgenic TCR targeting SALL4 for cancer immunotherapy

Affiliation auteurs!!!! Error affiliation !!!!
TitreDevelopment of engineered transgenic TCR targeting SALL4 for cancer immunotherapy
Type de publicationJournal Article
Year of Publication2021
AuteursBen Khelil M, Perchaud M, Spehner L, Asgarov K, Bouard A, Monnien F, Vienot A, Harari A, Jandus C, Kroemer M, Borg C, Loyon R
JournalEUROPEAN JOURNAL OF IMMUNOLOGY
Volume51
Pagination388
Date PublishedAUG
Type of ArticleMeeting Abstract
ISSN0014-2980
Mots-clésCancer immunology, cell based therapies, Immunotherapy